• Your Selections:

Refine Results

date

Topics

Content Type

Tags

Early State Vaccination Data Raise Warning Flags for Racial Equity

Across states, data to understand access to and uptake of the vaccine by race/ethnicity and other demographic factors will be central to efforts to ensure equity. KFF is compiling and will regularly update state-reported data on vaccination by race/ethnicity through its COVID-19 state data and policy tracker.

How are States Addressing Racial Equity in COVID-19 Vaccine Efforts?

This brief reviews information available through state websites and publicly available vaccine distribution plans to provide greater insight into how states are addressing equity through vaccine allocation and distribution strategies, outreach and communications efforts, and data collection and reporting. It provides a snapshot and examples of state efforts in these areas.

Texans’ Experiences with Health Care Affordability and Access

Using data from the Kaiser Family Foundation/Episcopal Health Foundation 2018 Texas Health Policy Survey, this brief explores Texas residents’ experiences with health care affordability and access to care. It examines Texans’ difficulty affording health care compared to other basic needs, problems paying medical bills, and skipping or postponing care because of costs. It also explores the experiences of vulnerable groups like the uninsured and those with lower incomes.

Hispanic People are Facing Widening Gaps in Health Coverage

New analysis shows that, in 2019, the number of uninsured continued to increase for the third year in a row. Much of the coverage loss between 2018 and 2019 was among Hispanic people, and these data point to significant increased barriers to health care for Hispanic people.

Who Didn’t Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines

As the U.S. prepares for nationwide distribution of vaccines to combat COVID-19, some are asking whether people who get the first of two doses will return to complete the series. This analysis draws on Medicare Part D prescription drug claims data for the herpes zoster vaccine Shingrix, which also requires two doses, to shed light on this potential challenge of the leading COVID-19 vaccine candidates.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.